These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 32539688)

  • 1. Hemodiafiltration with ultrafiltrate regeneration reduces free light chains without albumin loss in multiple myeloma patients.
    Pendón-Ruiz de Mier MV; Ojeda R; Álvarez-Lara MA; Navas A; Alonso C; Caballero-Villarraso J; Aljama P; Álvarez MA; Soriano S; Rodríguez M; Martín-Malo A
    BMC Nephrol; 2020 Jun; 21(1):227. PubMed ID: 32539688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of haemodiafiltration with ultrafiltrate regeneration in the reduction of light chains in multiple myeloma with renal failure.
    Pendón-Ruiz de Mier MV; Alvarez-Lara MA; Ojeda-López R; Martín-Malo A; Carracedo J; Caballero-Villarraso J; Alonso C; Aljama P
    Nefrologia; 2013 Nov; 33(6):788-96. PubMed ID: 24241366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum Free Light Chains Removal by HFR Hemodiafiltration in Patients with Multiple Myeloma and Acute Kidney Injury: a Case Series.
    Menè P; Giammarioli E; Fofi C; Antolino G; Verde G; Tafuri A; Punzo G; Festuccia F
    Kidney Blood Press Res; 2018; 43(4):1263-1272. PubMed ID: 30078004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel option for reducing free light chains in myeloma kidney: supra-hemodiafiltration with endogenous reinfusion (HFR).
    Pasquali S; Iannuzzella F; Corradini M; Mattei S; Bovino A; Stefani A; Palladino G; Caiazzo M
    J Nephrol; 2015 Apr; 28(2):251-4. PubMed ID: 25149172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy.
    Rousseau-Gagnon M; Agharazii M; De Serres SA; Desmeules S
    PLoS One; 2015; 10(10):e0140463. PubMed ID: 26466100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodiafiltration improves free light chain removal and normalizes κ/λ ratio in hemodialysis patients.
    Bourguignon C; Chenine L; Bargnoux AS; Leray-Moragues H; Canaud B; Cristol JP; Morena M
    J Nephrol; 2016 Apr; 29(2):251-257. PubMed ID: 26022721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between on-line high-efficiency hemodiafiltration and conventional high-flux hemodialysis for polyclonal free light chain removal.
    Lamy T; Henri P; Lobbedez T; Comby E; Ryckelynck JP; Ficheux M
    Blood Purif; 2014; 37(2):93-8. PubMed ID: 24603634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy.
    Hasegawa M; Kondo F; Yamamoto K; Murakami K; Tomita M; Nabeshima K; Nakai S; Kato M; Ohashi A; Arai J; Hiki Y; Ishii J; Emi N; Sugiyama S; Yuzawa Y
    Ther Apher Dial; 2010 Oct; 14(5):451-6. PubMed ID: 21175542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of free light chain removal by four blood purification methods.
    Kanayama K; Ohashi A; Hasegawa M; Kondo F; Yamamoto Y; Sasaki M; Hayashi H; Kato M; Hattori R; Yamashita H; Arai J; Ishii J; Emi N; Yuzawa Y
    Ther Apher Dial; 2011 Aug; 15(4):394-9. PubMed ID: 21884475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum free-light chain removal by high cutoff hemodialysis: optimizing removal and supportive care.
    Hutchison CA; Harding S; Mead G; Goehl H; Storr M; Bradwell A; Cockwell P
    Artif Organs; 2008 Dec; 32(12):910-7. PubMed ID: 19133018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of acute kidney injury in frail patients with biopsy-proven cast nephropathy: a combined approach with chemotherapy plus Supra-hemodiafiltration with post-adsorption endogenous reinfusion.
    Murgia S; Quattrocchio G; Forneris G; Pozzato M; Fenoglio R; Ferro M; De Simone E; Del Vecchio G; Di Benedetto C; Roccatello D
    J Nephrol; 2022 May; 35(4):1243-1249. PubMed ID: 34982413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Online high-efficiency haemodiafiltration achieves higher serum free light chain removal than high-flux haemodialysis in multiple myeloma patients: preliminary quantitative study.
    Granger Vallée A; Chenine L; Leray-Moragues H; Patrier L; Cognot C; Cartron G; Cristol JP; Canaud B
    Nephrol Dial Transplant; 2011 Nov; 26(11):3627-33. PubMed ID: 21508098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo removal of high- and low-molecular-weight compounds in hemodiafiltration with on-line regeneration of ultrafiltrate.
    Testa A; Gentilhomme H; Le Carrer D; Orsonneau JL
    Nephron Clin Pract; 2006; 104(1):c55-60. PubMed ID: 16741371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Freelite™ and N Latex serum free light chain assays in subjects with end stage kidney disease on haemodialysis.
    Kennard A; Hawley C; Tate J; Klingberg S; Pretorius C; Hutchison C; Mollee P
    Clin Chem Lab Med; 2016 Jun; 54(6):1045-52. PubMed ID: 26684350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel renal replacement strategies for the elimination of serum free light chains in patients with kappa light chain nephropathy.
    Kleeberg L; Morgera S; Jakob C; Hocher B; Schneider M; Peters H; Rötzer S; Müller C; Kaiser M; Fleissner C; Heider U; Neumayer HH; Sezer O
    Eur J Med Res; 2009; 14(2):47-54. PubMed ID: 19258212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A tRial Evaluating Mid Cut-Off Value Membrane Clearance of Albumin and Light Chains in HemoDialysis Patients: A Safety Device Study.
    Krishnasamy R; Hawley CM; Jardine MJ; Roberts MA; Cho Y; Wong M; Heath A; Nelson CL; Sen S; Mount PF; Pascoe EM; Vergara LA; Paul-Brent PA; Toussaint ND; Johnson DW; Hutchison CA
    Blood Purif; 2020; 49(4):468-478. PubMed ID: 31968346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodiafiltration with ultrafiltrate regeneration in the removal of free light chains in multiple myeloma and acute kidney injury.
    Li Cavoli G; Passanante S; Schillaci O; Servillo F; Zagarrigo C; Li Cavoli TV; Palmeri M; Palma B; Rotolo U
    Nefrologia (Engl Ed); 2018; 38(3):337-338. PubMed ID: 28757277
    [No Abstract]   [Full Text] [Related]  

  • 18. [Analysis of serum free light chains κ/λ ratio and heavy/light chain pairs of immunoglobulin to the stratification of multiple myeloma according to Mayo Stratification of Myeloma and Revised International Staging System].
    Ščudla V; Balcárková J; Lochman P; Vincová M; Pika T; Minařík J; Zapletalová J; Jarošová M
    Vnitr Lek; 2016 Apr; 62(4):269-80. PubMed ID: 27250604
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Flux dialyzer 2.6 m2 is promising for free light chains removal in high-flux hemodialysis and in hemodiafiltration.
    El-Sayed H; Abdelmohsen W; Abdelmegied S; Emara A; Sultan R; El-Sharkawy M
    Egypt J Immunol; 2022 Oct; 29(4):106-114. PubMed ID: 36206153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experience of using hemodialysis with medium cut-off dialyzer in cast nephropathy.
    Cazorla López JM; García García-Doncel A; Naranjo Muñoz J; Villanego Fernández F; Vigara Sánchez LA; Ceballos Guerrero M
    Nefrologia (Engl Ed); 2020; 40(3):367-369. PubMed ID: 32007298
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.